Delivery Order SPE2DB22D9316-SPE2DB25FYN15

Award Date 1/27/25
Potential Completion Date 2/18/25
Potential Value $62K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $57,317.20, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business based in Park Ridge, Illinois. The contract is a delivery order under a larger DLA indefinite delivery vehicle (IDV), contract SPE2DB, that has a ceiling value of up to $4,999,999 through 2025. Through this IDV, the DLA can issue firm fixed-price delivery orders for a broad range of pharmaceutical items to fulfill the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at up to $49,597.83, is for the delivery of 4559254463 - MACI 3CM X 5CM IMPLANT SHEETS. This is a firm fixed-price delivery order with no set-aside designation. The award is associated with a larger indefinite delivery contract (IDC) under the SPE2DB program, valued at up to...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a ceiling value of $57,317.20 for the procurement of MACI 3CM X 5CM IMPLANT SHEETS. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at up to $49,597.83, is a firm fixed-price delivery order for the supply of MACI 3CM X 5CM IMPLANT SHEETS. This award is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025....
This federal contract award, valued at $49,714.55, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a delivery order under the DLA's SPE2DB program, a $499,999,999 indefinite delivery contract that provides a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of Department of Defense (DoD) healthcare facilities worldwide. This...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $53,318.24, is for the delivery of MACI 3CM X 5CM Implant Sheets. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that allows the DLA to issue firm fixed-price orders for a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $53,318.24 firm fixed-price delivery order is for the provision of MACI 3CM X 5CM IMPLANT SHEETS, with an ultimate completion date of August 18, 2023. This award is made under the $499,999,999 DLA SPE2DB indefinite delivery contract that allows the agency...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $61,902.90 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4567084856 MACI 3CM X 5CM IMPLANT SHEETS, a specialized medical product, with a completion date of February 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $57,317.20 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4564605225 - MACI 3CM X 5CM IMPLANT SHEETS to fulfill the medical supply needs of military health facilities supported by DLA. This order is placed against DMS Pharmaceutical Group's broader $4,999,999 Indefinite Delivery Vehicle contract...
This federal contract award, valued at $57,317.20, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order under the DLA's SPE2DB indefinite delivery contract (IDC), which has a ceiling value of $499,999,999 and is valid through November 2026. The contract is for the delivery of 4566653511 MACI 3cm x 5cm implant sheets, a specialized...
  • SPE2DB22D9316
    Indefinite Delivery Contract
  • SPE2DB22D9316-SPE2DB25FYN15
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $61,902.91, is a firm fixed-price delivery order for the supply of 4567467472 ! MACI 3CM X 5CM IMPLANT SHEETS to the DLA. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories and medical domains.

Generated 4/28/25, 9:50 AM